Isn't CytRx also dabbling in RNAi? Saw they are up a fair amount today too. PR today says on getting Orphan Drug designation. I don't know why smaller BioTech/Pharma seem to move big on this. If it is an Orpahn indication I don't see it as worthy of a 30% move.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.